Stapled peptide-based membrane fusion inhibitors of hepatitis C virus

被引：61
|
作者：
Cui, Hong-Kui [1 ]
Qing, Jie [1 ]
Guo, Ye [1 ]
Wang, Yu-Jia [1 ]
Cui, Li-Jia [2 ,3 ]
He, Tian-Hua [2 ,3 ]
Zhang, Linqi [2 ,3 ]
Liu, Lei [1 ]
机构：
[1] Tsinghua Univ, Dept Chem, Tsinghua Peking Ctr Life Sci,Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China
[2] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China
[3] Tsinghua Univ, Sch Med, Res Ctr Publ Hlth, Beijing 100084, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 12期
基金：
中国国家自然科学基金;
关键词：
Hepatitis C virus; Stapled peptide; Protein-protein interaction; CELL-CULTURE SYSTEMS; B TYPE-I; OLEFIN METATHESIS; ALPHA-HELICES; BH3; HELIX; CD81; ENTRY; INFECTION; PROTEINS; RECEPTOR;
D O I：
10.1016/j.bmc.2013.02.011
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The strategy of peptide stapling was used to develop new molecules to inhibit the hepatitis C virus infection via disrupting the binding of HCV envelope glycoprotein E2 with human cell surface protein CD81. The peptide sequence was designed based on the large extra-cellular loop of CD81 with known importance in the HCV E2 binding interaction. Our results showed that the stapled peptides exhibited significantly higher alpha-helicity and proteolytic stability as compared to their linear peptide counterpart. The optimal compound was found to have an EC50 value of ca. 17-39 mu M against different HCV subtypes and represented a new HCV membrane fusion inhibitor. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3547 / 3554
页数：8
相关论文
共 50 条
  • [11] Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem Domain
    Chi, Xiaojing
    Niu, Yuqiang
    Cheng, Min
    Liu, Xiuying
    Feng, Yetong
    Zheng, Fuxiang
    Fan, Jingjing
    Li, Xiang
    Jin, Qi
    Zhong, Jin
    Li, Ping
    Yang, Wei
    SCIENTIFIC REPORTS, 2016, 6
  • [12] Systematic Evaluation of Fluorination as Modification for Peptide-Based Fusion Inhibitors against HIV-1 Infection
    Huhmann, Susanne
    Nyakatura, Elisabeth K.
    Rohrhofer, Anette
    Moschner, Johann
    Schmidt, Barbara
    Eichler, Jutta
    Roth, Christian
    Koksch, Beate
    CHEMBIOCHEM, 2021, 22 (24) : 3443 - 3451
  • [13] Peptide-Based Inhibitors of Fimbrial Biogenesis in Porphyromonas gingivalis
    Alaei, Sarah R.
    Park, Jin Ho
    Walker, Stephen G.
    Thanassi, David G.
    INFECTION AND IMMUNITY, 2019, 87 (03)
  • [14] Fluoxazolevir inhibits hepatitis C virus infection in humanized chimeric mice by blocking viral membrane fusion
    Ma, Christopher D.
    Imamura, Michio
    Talley, Daniel C.
    Rolt, Adam
    Xu, Xin
    Wang, Amy Q.
    Le, Derek
    Uchida, Takuro
    Osawa, Mitsutaka
    Teraoka, Yuji
    Li, Kelin
    Hu, Xin
    Park, Seung Bum
    Chalasani, Nishanth
    Irvin, Parker H.
    Dulcey, Andres E.
    Southall, Noel
    Marugan, Juan J.
    Hu, Zongyi
    Chayama, Kazuaki
    Frankowski, Kevin J.
    Liang, Tsanyang Jake
    NATURE MICROBIOLOGY, 2020, 5 (12) : 1532 - +
  • [15] Structure-based design of hepatitis C virus inhibitors
    Smith, RM
    Wu, GY
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (06) : 405 - 412
  • [16] Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions
    Wang, Xuefei
    Ni, Duan
    Liu, Yaqin
    Lu, Shaoyong
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [17] Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
    Perin, Paula M.
    Haid, Sibylle
    Brown, Richard J. P.
    Doerrbecker, Juliane
    Schulze, Kai
    Zeilinger, Carsten
    von Schaewen, Markus
    Heller, Brigitte
    Vercauteren, Koen
    Luxenburger, Eva
    Baktash, Yasmine M.
    Vondran, Florian W. R.
    Speerstra, Sietkse
    Awadh, Abdullah
    Mukhtarov, Furkat
    Schang, Luis M.
    Kirschning, Andreas
    Mueller, Rolf
    Guzman, Carlos A.
    Kaderali, Lars
    Randall, Glenn
    Meuleman, Philip
    Ploss, Alexander
    Pietschmann, Thomas
    HEPATOLOGY, 2016, 63 (01) : 49 - 62
  • [18] Structure and Function of the SARS-CoV-2 6-HB Fusion Core and Peptide-based Fusion Inhibitors: A Review
    Liang, Guodong
    Li, Yue
    Li, Ruijuan
    Ma, Yuheng
    Na, Heiya
    CURRENT MEDICINAL CHEMISTRY, 2023,
  • [19] New small molecule inhibitors of hepatitis C virus
    Wei, Wanguo
    Cai, Cuifang
    Kota, Smitha
    Takahashi, Virginia
    Ni, Feng
    Strosberg, A. Donny
    Snyder, John K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (24) : 6926 - 6930
  • [20] Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors
    Su, Shan
    Zhu, Yun
    Ye, Sheng
    Qi, Qianqian
    Xia, Shuai
    Ma, Zhenxuan
    Yu, Fei
    Wang, Qian
    Zhang, Rongguang
    Jiang, Shibo
    Lu, Lu
    JOURNAL OF VIROLOGY, 2017, 91 (01)
12345